Search Results - "VAISSIERE, Nathalie"

Phase III Trial Comparing Vinflunine With Docetaxel in Second-Line Advanced Non–Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy by KRZAKOWSKI, Maciej, RAMLAU, Rodryg, DELGADO, François M, SALHI, Yacine, VAISSIERE, Nathalie, HANSEN, Olfred, TAN, Eng-Huat, QUOIX, Elisabeth, GARRIDO, Pilar, DOUILLARD, Jean-Yves, JASSEM, Jacek, SZCZESNA, Aleksandra, ZATLOUKAL, Petr, VON PAWEL, Joachim, XUSHAN SUN, BENNOUNA, Jaafar, SANTORO, Armando, BIESMA, Bonne

“…To compare vinflunine (VFL) to docetaxel in patients with stage IIIB/IV non-small-cell lung cancer (NSCLC) who have experienced treatment failure with…”
Get full text

Ad26.COV2.S COVID-19 vaccine safety and immunogenicity in adolescents 16-17 years of age by Ruiz-Guiñazú, Javier, Le Gars, Mathieu, Cárdenas, Vicky, Vaissière, Nathalie, Sadoff, Jerald, Truyers, Carla, Hendriks, Jenny, Scheper, Gert, de Groot, A Marit, Struyf, Frank, Schuitemaker, Hanneke, Douoguih, Macaya

“…2.5 × 1010 vp Ad26.COV2.S elicited robust SARS-CoV-2–specific antibody responses in adolescents through 6 months, with acceptable safety and reactogenicity…”
Get full text

Durable antibody responses elicited by 1 dose of Ad26.COV2.S and substantial increase after boosting: 2 randomized clinical trials by Sadoff, Jerald, Le Gars, Mathieu, Brandenburg, Boerries, Cárdenas, Vicky, Shukarev, Georgi, Vaissiere, Nathalie, Heerwegh, Dirk, Truyers, Carla, de Groot, Anne Marit, Jongeneelen, Mandy, Kaszas, Krisztian, Tolboom, Jeroen, Scheper, Gert, Hendriks, Jenny, Ruiz-Guiñazú, Javier, Struyf, Frank, Van Hoof, Johan, Douoguih, Macaya, Schuitemaker, Hanneke

“…•One dose of Ad26.COV2.S elicited high neutralizing and binding antibody levels.•Antibody levels persisted through 8 months (neutralizing) and 6 months…”
Get full text

GILT—A randomised phase III study of oral vinorelbine and cisplatin with concomitant radiotherapy followed by either consolidation therapy with oral vinorelbine and cisplatin or best supportive care alone in stage III non-small cell lung cancer by Flentje, Michael, Huber, Rudolf M., Engel-Riedel, Walburga, Andreas, Stefan, Kollmeier, Jens, Staar, Susanne, Dickgreber, Nicolas, Vaissiere, Nathalie, De Almeida, Cecilia, Edlich, Birgit, Fietkau, Rainer

“…Background Concurrent chemoradiotherapy (CRT) is considered standard for inoperable stage III non-small cell lung cancer (NSCLC). Consolidation chemotherapy…”
Get full text

Oral Vinorelbine Plus Cisplatin as First-Line Chemotherapy in Nonsquamous Non–Small-Cell Lung Cancer: Final Results of an International Randomized Phase II Study (NAVotrial 01) by Bennouna, Jaafar, Havel, Libor, Krzakowski, Maciej, Kollmeier, Jens, Gervais, Radj, Dansin, Eric, Serke, Monika, Favaretto, Adolfo, Szczesna, Aleksandra, Cobo, Manuel, Ciuffreda, Libero, Jassem, Jacek, Nicolini, Mario, Ramlau, Rodryg, Amoroso, Domenico, Melotti, Barbara, Almodovar, Teresa, Riggi, Marcello, Caux, Noël-Raphaël, Vaissière, Nathalie, Tan, Eng-Huat

“…Micro-Abstract Two cisplatin-based doublets with either oral vinorelbine or pemetrexed were tested in patients with Nonsquamous Non–Small-Cell Lung Cancer in a…”
Get full text

Phase II study of oral vinorelbine in combination with carboplatin followed by consolidation therapy with oral vinorelbine as single-agent in unresectable localized or metastatic non-small cell lung carcinoma by Reck, Martin, Macha, Hans-Nikol, Del Barco, Sonia, Cornes, Paul, Vaissière, Nathalie, Morand, Maryse, Riggi, Marcello, Abratt, Raymond

“…Abstract Introduction This phase II study assessed the efficacy and safety of oral vinorelbine given weekly in combination with carboplatin (CBDCA) AUC 5 once…”
Get full text

Impact of histology on survival of resected non-small cell lung cancer (NSCLC) receiving adjuvant chemotherapy: Subgroup analysis of the adjuvant vinorelbine (NVB) cisplatin (CDDP) versus observation in the ANITA trial by Bennouna, Jaafar, Senellart, Hélène, Hiret, Sandrine, Vaissiere, Nathalie, Douillard, Jean-Yves

“…Summary Background Data issued from the survival outcome in the ANITA trial are reported according to histology in observation ( n = 433) and adjuvant…”
Get full text

Phase II study of a triple combination of oral vinorelbine, capecitabine and trastuzumab as first-line treatment in HER2-positive metastatic breast cancer by Chan, Arlene, Conte, Pier-Franco, Petruzelka, Lubos, Tubiana-Mathieu, Nicole, Ganju, Vinod, Llombart, Antonio, Espie, Marc, Majois, Françoise, Gil, Miguel Gil, Vaissiere, Nathalie, Villanova, Gustavo

“…Chemotherapy plus trastuzumab is the standard first-line treatment for Human Epidermal Receptor 2-positive (HER2-positive) metastatic breast cancer. The aim of…”
Get full text

GILT study: Oral vinorelbine (NVBo) and cisplatin (P) with concomitant radiotherapy (RT) followed by either consolidation (C) with NVBo plus P plus best supportive care (BSC) or BSC alone in stage (st) III non-small cell lung cancer (NSCLC): Final results of a phase (ph) III study by Huber, Rudolf M., Engel-Riedel, Walburga, Kollmeier, Jens, Andreas, Stefan, Staar, Susanne, Klautke, Gunther, Fietkau, Rainer, Vaissiere, Nathalie, Osowski, Susanne, Flentje, Michael

“…Abstract only 7001 Background: Concurrent chemo-radiotherapy (CT-RT) is considered as a standard in st III NSCLC. Published trials with C after CT-RT show…”
Get full text

Prospective randomised phase II trial of oral vinorelbine (NVBo) and cisplatin (P) or pemetrexed (Pem) and P in first-line metastatic or locally advanced non-small cell lung cancer (M or LA NSCLC) with nonsquamous (Non SCC) histological type. NAVoTRIAL01: Final results by Bennouna, Jaafar, Havel, Libor, Krzakowski, Maciej, Kollmeier, Jens, Gervais, Radj, Dansin, Eric, Serke, Monika, Favaretto, Adolfo G., Cobo, Manuel, Szczesna, Aleksandra, Ciuffreda, Libero, Jassem, Jacek, Nicolini, Mario, Ramlau, Rodryg, Amoroso, Domenico, Melotti, Barbara, Almodovar, Teresa, Vaissiere, Nathalie, Riggi, Marcello, Tan, Eng Huat

“…Abstract only 8043 Background: NVBo+P is considered as a standard treatment in M or LA NSCLC. The recent approval of Pem+P as front line chemotherapy (CT) for…”
Get full text